It may also be used as a maintenance dose after significant weight loss has already been achieved, she added
GLP-1s, first approved for type 2 diabetes in 2005, lower blood glucose, help avoid fatty liver disease, and help with obesity-related problems such as knee pain, sleep apnea, and gastroesophageal reflux
Dosage regimens for GLP-1 receptor agonists vary depending on the specific medication, indication (type 2 diabetes or weight management), and individual patient factors
Combining GLP-1 pathway medications with some other commonly used T2D medications (for example thiazolidinediones or sulfonylureas) may not have an additional benefit
Am J Physiol Cell Physiol 328(6): C1793C1807
7 Conclusion and future directions Future research should focus on translating preclinical findings to human applications, particularly through chronobiological studies of hormonal-taste interactions and advanced computational modeling of individual taste-metabolism relationships